Endonovo Therapeutics pulls in $10 million in return for a promissary note to an unnamed investor.
Endonovo Therapeutics said it raised $10 million in a private placement with an unnamed investor.
The Woodland Hills, Calif.-based company is developing non-invasive, electromagnetic therapies with time-varying electromagnetic fields to regenerate tissue and organs that have been damaged by age or disease.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/MRRkcr
Cap comentari:
Publica un comentari a l'entrada